Advertisement
Screener

INTENSITY THERAPEUTICS, INC. (INTS) Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

2.8 / 5 stars · 68/120 Roast Me

INTENSITY THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount

INTENSITY THERAPEUTICS, INC. (INTS) reported Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount of $2.39 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.

Financial Statements › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance · last filed 2026-03-27

  • INTENSITY THERAPEUTICS, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2025 was $2.39M, a 26.91% decline from fiscal 2024.
  • INTENSITY THERAPEUTICS, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2024 was $3.27M, a 73.04% increase from fiscal 2023.
  • INTENSITY THERAPEUTICS, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2023 was $1.89M, a 22.36% increase from fiscal 2022.
  • INTENSITY THERAPEUTICS, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2022 was $1.54M.
Period endEffective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount 12 monthEffective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount 12 month as first filed
2025-12-31$2.39M
10-K · filed 2026-03-27
2024-12-31$3.27M
10-K · filed 2026-03-27
$4.22M
10-K · filed 2025-03-13
2023-12-31$1.89M
10-K · filed 2025-03-13
2022-12-31$1.54M
10-K · filed 2024-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
Pluri Inc. (PLUR)$0.014B
IN8BIO, INC. (INAB)United States$0.012B-0.76
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Passage BIO, Inc. (PASG)United States$0.015B-0.43
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
BioCardia, Inc. (BCDA)United States$0.016B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37